Partial Response of Multiple Myeloma or Plasma Cell Leukemia
1 clinical trials · Condition
◉ Watch Partial Response of Multiple Myeloma or Plasma Cell Leukemia
| Record | Firm | Date |
|---|---|---|
| SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy (NCT02334865) | Roswell Park Cancer Institute | 2017-04-13 |
Track Partial Response of Multiple Myeloma or Plasma Cell Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.